JP2024514962A5 - - Google Patents
Info
- Publication number
- JP2024514962A5 JP2024514962A5 JP2023565307A JP2023565307A JP2024514962A5 JP 2024514962 A5 JP2024514962 A5 JP 2024514962A5 JP 2023565307 A JP2023565307 A JP 2023565307A JP 2023565307 A JP2023565307 A JP 2023565307A JP 2024514962 A5 JP2024514962 A5 JP 2024514962A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- sequence
- optionally
- aavrh74
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163179097P | 2021-04-23 | 2021-04-23 | |
| US63/179,097 | 2021-04-23 | ||
| US202263327410P | 2022-04-05 | 2022-04-05 | |
| US63/327,410 | 2022-04-05 | ||
| PCT/US2022/025916 WO2022226289A2 (en) | 2021-04-23 | 2022-04-22 | Aavrh74 vectors for gene therapy of muscular dystrophies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514962A JP2024514962A (ja) | 2024-04-03 |
| JP2024514962A5 true JP2024514962A5 (cg-RX-API-DMAC7.html) | 2025-05-01 |
Family
ID=81648417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565307A Pending JP2024514962A (ja) | 2021-04-23 | 2022-04-22 | 筋ジストロフィーの遺伝子治療のためのaavrh74ベクター |
Country Status (13)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2623605T3 (en) | 2007-04-09 | 2019-03-25 | Univ Florida | RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF |
| US12358954B2 (en) | 2012-05-15 | 2025-07-15 | University Of Florida Research Foundation, Incorporated | Capsid-modified rAAV vector compositions and methods therefor |
| US10294281B2 (en) | 2012-05-15 | 2019-05-21 | University Of Florida Research Foundation, Incorporated | High-transduction-efficiency rAAV vectors, compositions, and methods of use |
| KR20240095539A (ko) | 2021-10-08 | 2024-06-25 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 변이체 및 이의 사용 방법 |
| WO2024184781A1 (en) * | 2023-03-03 | 2024-09-12 | Universitat Heidelberg | Engineered aav capsids |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6342886B2 (ja) * | 2012-04-18 | 2018-06-13 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia | Aavカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法 |
| EP3221456B1 (en) | 2014-11-21 | 2021-09-22 | University of Florida Research Foundation, Inc. | Genome-modified recombinant adeno-associated virus vectors |
| JP7785352B2 (ja) * | 2019-08-14 | 2025-12-15 | ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. | 遺伝子治療のためのaavカプシドバリアント |
-
2022
- 2022-04-22 JP JP2023565307A patent/JP2024514962A/ja active Pending
- 2022-04-22 US US18/287,711 patent/US20240181083A1/en active Pending
- 2022-04-22 KR KR1020237039756A patent/KR20240000542A/ko active Pending
- 2022-04-22 EP EP22723290.7A patent/EP4326857A2/en active Pending
- 2022-04-22 IL IL307881A patent/IL307881A/en unknown
- 2022-04-22 MX MX2023012509A patent/MX2023012509A/es unknown
- 2022-04-22 AU AU2022262407A patent/AU2022262407A1/en active Pending
- 2022-04-22 TW TW111115475A patent/TW202304954A/zh unknown
- 2022-04-22 CA CA3217649A patent/CA3217649A1/en active Pending
- 2022-04-22 BR BR112023021495A patent/BR112023021495A2/pt unknown
- 2022-04-22 WO PCT/US2022/025916 patent/WO2022226289A2/en not_active Ceased
- 2022-04-22 US US17/727,007 patent/US20220347317A1/en not_active Abandoned
-
2023
- 2023-10-18 CL CL2023003102A patent/CL2023003102A1/es unknown
- 2023-11-22 CO CONC2023/0015911A patent/CO2023015911A2/es unknown
-
2024
- 2024-08-27 CL CL2024002556A patent/CL2024002556A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI908746B (zh) | 微小肌縮蛋白基因療法之構築體及其用途 | |
| CN112004925B (zh) | 具有降低的肝向性的AAV9和AAVrh74的杂合重组腺相关病毒血清型 | |
| EP2940131B1 (en) | Aav variant | |
| JP2025106514A (ja) | 脳内への特異性が増強されたウイルス組成物 | |
| JP2026027271A5 (cg-RX-API-DMAC7.html) | ||
| Foster et al. | Gene therapy progress and prospects: Duchenne muscular dystrophy | |
| CN109652385A (zh) | 外显子2靶向U7snRNA多核苷酸构建体的重组腺相关病毒递送 | |
| JP2021528983A5 (cg-RX-API-DMAC7.html) | ||
| US20220347317A1 (en) | Aavrh74 vectors for gene therapy of muscular dystrophies | |
| CN113747926A (zh) | 用于肌肉表达的杂合启动子 | |
| WO2020142714A1 (en) | Aav expression cassette and aav vectors comprising the same | |
| US20240409955A1 (en) | Auf1 combination therapies for treatment of muscle degenerative disease | |
| KR20250166360A (ko) | 페이로드 전달을 위한 rgd-함유 펩티드 | |
| US20250066437A1 (en) | Transgenic expression cassette for treating muscular dystrophy | |
| US20250346921A1 (en) | An optimized aav vector for gene therapy of muscular dystrophy | |
| WO2023190935A1 (en) | Method for treating myopathies by targeting titin gene | |
| WO2025232917A1 (en) | Novel liver detargeted aav variants and uses thereof | |
| KR20250139307A (ko) | 파지 벡터 | |
| CN117355603A (zh) | 用于肌营养不良的基因治疗的aavrh74载体 | |
| TW202528335A (zh) | 衣殼多肽及其使用方法(一) | |
| WO2025125692A1 (en) | Viral vector for transduction of adipocytes | |
| WO2025039622A1 (zh) | 经修饰的腺相关病毒载体及其在治疗中枢神经系统疾病中的用途 | |
| HK40030612A (en) | Viral vector for the targeted transfer of genes in the brain and spinal cord | |
| WO2021237104A1 (en) | Methods and compositions to spread protein cargoes across multi-nucleated cells | |
| IL293334A (en) | Microdystrophin gene therapy constructs and uses thereof |